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What Will Noninvasive
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Imaging Show Us About
High-Risk Coronary Plaques?*
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Seattle, Washington
With the advent of many noninvasive imaging techniques to
characterize atherosclerotic plaques in vivo, it is time to
investigate the relationships of high-risk lesions in different
vascular beds as a systemic disease.
See page 416
The quest to noninvasively identify vulnerable athero-
sclerotic plaques that pose an increased risk of heart
attack and stroke may have gained another tool in
magnetic resonance imaging (MRI). Vulnerable plaque
imaging remains a challenging field for many reasons:
from the spatial resolution needed to identify thin cap
fibroatheroma in the coronary arteries, to quantifying the
amount of lipid content and inflammation in plaques (1).
The technical challenges are further compounded by
there perhaps being multiple vulnerable plaques in a
single vascular bed (i.e., coronary arteries), and as a
systemic disease, atherosclerosis may develop in multiple
vascular beds (2). Direct noninvasive coronary vulnerable
plaque imaging (with computed tomography) remains
limited to the examination of calcium deposits and
categorization of lesions as hard versus soft plaque rather
than a direct characterization of thin cap fibroatheroma
or other high-risk features (3). In this issue of the Journal,
Noguchi et al. (4) suggest a direct plaque imaging
approach to predict risk of future cardiovascular events.
In this case, the direct plaque imaging technique is
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arteries. The authors demonstrate that these “high-risk”
signals in the carotids can help predict coronary events.
With a larger size, easy access by many imaging
techniques, and less motion compared to the coronary
arteries, it is natural that carotid artery atherosclerosis be
considered as a surrogate for coronary artery disease. In
particular, increased carotid intima media thickness
(IMT) has been shown to be associated with increased
risk of cardiovascular disease events (5), although the
nature of this association is controversial. Carotid IMT,
obtained from B-mode ultrasound, is not a direct mea-
sure of carotid plaque, and a recent summary of meta-
analyses concludes that regression or slowed progression
of carotid IMT does not reflect reduction in cardiovas-
cular events (6). The true value of using the carotid artery
as a surrogate of coronary artery disease may lie in linking
the specific high-risk atherosclerotic lesions or lesion
features in the 2 vascular beds. Indeed, in a large study of
the histological features of plaques obtained from pa-
tients undergoing carotid endarterectomy, Hellings et al.
(7) showed that presence of carotid plaque hemorrhage or
marked intraplaque vessel formation predicted an in-
creased risk for composite events (vascular death, nonfa-
tal stroke, nonfatal myocardial infarction) during follow-
up. While this study provides compelling evidence of a
possible linkage between “high-risk” plaque features
across vascular beds in patients requiring carotid surgery,
the findings by Noguchi et al. (4) suggest that this
association holds true among those with earlier stage,
asymptomatic carotid atherosclerosis.
The bright T1 signal in MRI reported in this study is
believed to be from intraplaque hemorrhage (IPH) and
likely due to the degradation of hemorrhage into methe-
moglobin. Methemoglobin shortens the longitudinal re-
laxation time (T1) and gives the bright signals in T1-
weighted images such as in the magnetization-prepared
rapid acquisition gradient echo (MPRAGE) and time-
of-flight and fast spin echo techniques. Each of these
sequences has been validated with histology to detect
IPH in the carotid atherosclerosis (8 –13). More impor-
tantly, a series of prospective and cross-sectional studies
have found a clear link between IPH and accelerated
progression in carotid plaque burden, as well as associa-
tions between carotid IPH and the development of future
ischemic neurological events (14 –18).
The MRI studies of persons with asymptomatic, min-
imal carotid stenosis have demonstrated a surprisingly
high prevalence of carotid plaques with IPH (19,20) and
highlight the limitation of stenotic severity as the prin-
cipal criterion for disease assessment. In the cohort
reported by Noguchi et al. (4), 50% of the carotid
plaques had MRI evidence of IPH, yet they had a mean
stenosis of only 22.5%. Recently, a carotid atherosclerosis
scoring system was introduced by Underhill et al. (21) to
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plaque burden and the size of plaque features such as the
lipid-rich necrotic core were more strongly associated
with IPH presence than with the severity of luminal
narrowing.
The work of Noguchi et al. (4) is exciting and promising,
but there are also several limitations associated with this
study. Given the prominent role that high-intensity plaques
(HIP) play in their report, there is no analysis with a
continuous formulation of HIP that, in theory, reflects the
size of intraplaque hemorrhage of a plaque and may enhance
the statistical power of the study. It would also be useful to
see if there is a dose-response relationship between contin-
uous HIP and the risk of an event. Likewise, the reliability
and robustness of HIP detection for general clinical appli-
cation needs to be assessed.
The subjects selected for this study had confirmed carotid
atherosclerosis and stable coronary artery disease. Transla-
tion of the main findings from this study to a more general
high-risk population will be challenging. Interestingly, a
recent MRI-based study (22) found that among subjects
with confirmed CAD, only 9.7% had carotid plaques with
intraplaque hemorrhage. It is clear that all these subjects
belong to the high-risk population, but whether there is a
better tailored diagnosis and treatment for a subset within
this population remains to be seen.
Another observation from the study is the very abrupt
decrease in risk of an event in the HIP group at about 18 to
20 months, with the curve leveling off considerably and a
much weaker (and perhaps nonexistent) leveling off in the
non-HIP group a little later (Fig. 2). That seems to suggest
a statistically significant and approximately eightfold de-
crease in risk of an event per unit time comparing months 0
to 20 to months 20 to 40. That clearly needs further study
and explanation.
Future work. The paper by Noguchi et al. (4) provides a
strong start in the effort to test the hypothesis that high-risk
plaque features are expressed systemically. Larger, multi-
center studies are needed to confirm these promising initial
findings. A key question is how plaque imaging should alter
patient management. Ongoing studies such as the High-
Risk Plaque Initiative (23) will provide valuable insight
toward identifying persons who by current clinical guide-
lines are considered low to intermediate risk, and as such are
currently not aggressively managed, and who may benefit
from MRI plaque imaging.
Finally, what is even more exciting is that the study has
been conducted through noninvasive imaging, and thus
offers the potential to examine the changes in these lesions
over time. Prospective, serial studies with MRI will result in
a better understanding of the nature and etiology of IPH,
may lead to the discovery of novel therapies to prevent its
development, and will be needed to assess whether such
therapies lead to a reduction in coronary and carotid events.Reprint requests and correspondence: Dr. Chun Yuan, Univer-
sity of Washington, Radiology, Box 358050, 815 Mercer Street,
Seattle, Washington 98109. E-mail: cyuan@u.washington.edu.
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